Drug Candidate Services
-
Manufactured by Inovotion Sasbased in FRANCE
Pharmaceutical chemical and biology researchers need to develop new methods and models to improve the predictivity of preclinical discovery phases and increase the number of good molecules in clinic. INOVOTION’s unique in vivo technology will allow you to raise the global number of drug candidates tested in clinic without increasing ...
-
by Solvias AGbased in SWITZERLAND
Most drug substances are marketed as crystalline material. Having a crystalline drug candidate is beneficial to development processes and simplifies registration. We offer crystallization screening services and also complete crystallization development ...
-
Manufactured by Creative Biolabsbased in CHINA
ADMET stands as an abbreviation for absorption, distribution, metabolism, excretion, and toxicity in pharmacokinetics and pharmacology. These properties describe the reaction of a drug medication within an organism, human, or animal, which helps scientists evaluate their drug candidates and select compounds that are likely to have the ...
-
based in USA
Cell-based assays are valuable to probe new drug candidates in the environment of intact cells with physiologic concentrations of substrates, co-factors and ...
-
based in USA
Simple : CarbonAI searches over 1.9 billion compounds to create synthesizable drug candidates – based only on target sequence. Precise : CarbonAI accurately identifies the most active and safe compound with a multi-objective optimization ...
-
Manufactured by Creative Biolabsbased in CHINA
engineering technology, development of genetic engineered antibody as drug candidates is growing rapidly such as antibody-drug conjugates (ADC), bispecific antibody, chimeric antibody, humanized antibody, and single-domain antibody ...
-
Manufactured by Cellworks Research India Private Limitedbased in
Accelerate drug development timelines, reduce risks and lower costs. Our biosimulation platform predicts human clinical response to investigational drug candidates YEARS earlier than traditional development ...
-
Manufactured by Creative Bioarraybased in USA
the properties of the liver, researchers can evaluate the metabolism, drug-drug interaction and toxicity of drug candidates in a cost-effective ...
-
Manufactured by Creative Biolabsbased in CHINA
Prior to clinical trials, it is necessary to conduct animal toxicity studies to best characterize the potential toxicity of new drug candidates. Generally, the objective of preclinical safety evaluation is to determine the toxic effects with respect to target organs, dose dependency, the relationship between clinical findings and ...
-
Manufactured by Jubilant Therapeutics Inc.based in USA
Agile and flexible to accelerate value creation. Jubilant Therapeutics is open for partnering or strategic. collaborations with biotech, pharma, academia, research labs for: Accelerating clinical development and market launch of our ongoing programs. Discovery/development of new programs in synergistic areas. Conducting research with our ...
-
by Molsoft LLCbased in USA
investment and yields a minimal number of potential drug candidates. As an alternative to performing traditional high throughput screening, Molsoft's Virtual Ligand Screening methodology can conduct in silico high throughput screening of multi-million vendor or combi-chem compound libraries while experimentally testing only a few hundred or ...
-
Manufactured by Inovotion Sasbased in FRANCE
Target validation is an essential and critical phase of the drug discovery process. This is a crucial step before starting to develop a treatment based on a targeted protein that has been identified to play a role in the disease. The target protein’s role must be clearly identified before starting to develop a drug candidate ...
-
Manufactured by Creative Biolabsbased in CHINA
Pharmacokinetics (PK) dedicated to determining the mechanisms of a drug's absorption, biodistribution, when it eliminated from the body and what it becomes. It is a study of how an organism affects a drug. In vivo PK studies are critical to ensure drug candidates have appropriate PK properties that can be evaluated in preclinical ...
-
Manufactured by Alfa Chemistrybased in USA
One of the most important steps in the process of developing a medicine is determining its safety. Alfa Chemistry is dedicated to providing pre-clinical drug research services to support our clients' drug development, pre-clinical and clinical investigations, and assist them in deciding which drug candidates are most worthwhile ...
-
Manufactured by Atriva Therapeutics GmbHbased in GERMANY
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two disease areas with urgent need for effective ...
-
Manufactured by Galapagos NVbased in BELGIUM
drug candidates and medicines. Galapagos supports external research through unsolicited funding requests. These are evaluated through our Investigator Sponsored Research (ISR) process. ...
-
by OHS Inc.based in USA
An OHS Inc. specialty is onsite drug testing: from 10 to 1,010 of your employees or your job candidates! Drug tests administered at your company's offices, job sites, or job fairs, anywhere in the ...
-
Manufactured by Charles Riverbased in USA
Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with ...
-
Manufactured by Kymab, a Sanofi companybased in UNITED KINGDOM
Our efforts in haematology are currently focussed on non-malignant blood disorders including forms of anaemia. Our approach is to identify functional and developable lead molecules and quickly proceed to verified animal disease models to study the direct impact of our drug candidates with clinically relevant read outs. We build our ...
-
Manufactured by CENTOGENE N.V.based in GERMANY
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you